iNeo-Vac-T01
/ Hangzhou Neoantigen Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 18, 2025
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
(clinicaltrials.gov)
- P1/2 | N=20 | Recruiting | Sponsor: Zhejiang University
New P1/2 trial • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1